Citadel Advisors’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$434K Sell
132,600
-558,370
-81% -$2.11M ﹤0.01% 9645
2025
Q4
$2.92M Buy
690,970
+328,370
+91% +$1.61M ﹤0.01% 5220
2025
Q3
$2.16M Buy
362,600
+142,620
+65% +$696K ﹤0.01% 5921
2025
Q2
$933K Sell
219,980
-100,900
-31% -$489K ﹤0.01% 7257
2025
Q1
$1.41M Buy
320,880
+149,380
+87% +$706K ﹤0.01% 6212
2024
Q4
$729K Buy
171,500
+15,200
+10% +$74.6K ﹤0.01% 7724
2024
Q3
$919K Sell
156,300
-43,170
-22% -$256K ﹤0.01% 7042
2024
Q2
$922K Sell
199,470
-42,880
-18% -$272K ﹤0.01% 6755
2024
Q1
$1.06M Buy
242,350
+196,250
+426% +$760K ﹤0.01% 6789
2023
Q4
$220K Buy
46,100
+9,520
+26% +$45.9K ﹤0.01% 9760
2023
Q3
$214K Buy
36,580
+19,220
+111% +$112K ﹤0.01% 9771
2023
Q2
$92.8K Sell
17,360
-14,040
-45% -$82.8K ﹤0.01% 11048
2023
Q1
$219K Sell
31,400
-9,380
-23% -$82.1K ﹤0.01% 10017
2022
Q4
$376K Sell
40,780
-10,090
-20% -$120K ﹤0.01% 8844
2022
Q3
$621K Sell
50,870
-12,910
-20% -$190K ﹤0.01% 7988
2022
Q2
$842K Buy
63,780
+3,030
+5% +$75.9K ﹤0.01% 7432
2022
Q1
$2.43M Buy
60,750
+3,540
+6% +$150K ﹤0.01% 5664
2021
Q4
$3.1M Sell
57,210
-43,598
-43% -$2.93M ﹤0.01% 5277
2021
Q3
$6.98M Sell
100,808
-145,872
-59% -$10.4M ﹤0.01% 3685
2021
Q2
$22.3M Buy
246,680
+173,880
+239% +$15.1M 0.01% 1947
2021
Q1
$6.78M Buy
72,800
+19,790
+37% +$2.21M ﹤0.01% 3655
2020
Q4
$4.41M Buy
53,010
+29,470
+125% +$2.15M ﹤0.01% 3891
2020
Q3
$1.09M Sell
23,540
-1,480
-6% -$141K ﹤0.01% 5876
2020
Q2
$3.11M Buy
25,020
+3,470
+16% +$395K ﹤0.01% 3804
2020
Q1
$2.34M Buy
21,550
+848
+4% +$151K ﹤0.01% 3896
2019
Q4
$5.37M Buy
20,702
+11,065
+115% +$4.13M ﹤0.01% 2991
2019
Q3
$5.08M Buy
9,637
+4,175
+76% +$3.09M ﹤0.01% 3095
2019
Q2
$5.13M Sell
5,462
-3,622
-40% -$3.64M ﹤0.01% 3043
2019
Q1
$9.88M Buy
9,084
+7,996
+735% +$7.15M ﹤0.01% 2094
2018
Q4
$648K Buy
+1,088
New +$802K ﹤0.01% 5994

Other funds holding ACB

Citadel Advisors's ACB Position: Q1 2026 in Review

Citadel Advisors increased its Aurora Cannabis (ACB) stake by 1.3% in Q1 2026, buying an estimated $11.9K and bringing the position to 252,312 shares worth $825K. The position accounts for ﹤0.01% of the portfolio, ranked #8105.

Citadel Advisors first reported a position in ACB in Q4 2018 and has held it in 27 quarters since. The position peaked at $14.9M in Q1 2021. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

  • Citadel Advisors held 252,312 shares of Aurora Cannabis worth $825K as of Q1 2026.
  • Citadel Advisors bought 3,139 Aurora Cannabis shares in Q1 2026, an estimated $11.9K.
  • Aurora Cannabis made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8105 holding.
  • Citadel Advisors first reported a position in Aurora Cannabis in Q4 2018 and has held it in 27 quarters since.
  • Citadel Advisors's Aurora Cannabis position peaked at $14.9M in Q1 2021.
  • 155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.